Fuji, Japan

Shiro Miyoshi



Average Co-Inventor Count = 2.2

ph-index = 6

Forward Citations = 70(Granted Patents)


Location History:

  • Kashiwa, JP (1993 - 1994)
  • Sizuoka, JP (2001 - 2003)
  • Shizuoka, JP (2000 - 2009)
  • Fuji, JP (2001 - 2009)

Company Filing History:


Years Active: 1993-2009

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Shiro Miyoshi: Innovator in Pharmaceutical Compounds

Introduction

Shiro Miyoshi is a prominent inventor based in Fuji, Japan. He has made significant contributions to the field of pharmaceuticals, holding a total of 12 patents. His work primarily focuses on innovative compounds that have potential therapeutic applications.

Latest Patents

Miyoshi's latest patents include the development of indazole compounds as B3 adrenoceptor agonists. These compounds are characterized by a general formula that includes various functional groups, providing a foundation for further research and application. Another notable patent is for a bicyclic compound, which is represented by a specific formula and is noted for its parathyroid hormone depressing action and low toxicity. This compound also has potential as an active ingredient in medicaments.

Career Highlights

Throughout his career, Shiro Miyoshi has worked with notable companies such as Asahi Kasei Kogyo and Asahi Kasei Pharma Corporation. His experience in these organizations has allowed him to develop and refine his innovative ideas in pharmaceutical research.

Collaborations

Miyoshi has collaborated with esteemed colleagues, including Kohei Ogawa and Shunichi Ikuta. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Shiro Miyoshi's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a key inventor. His work continues to influence the development of new therapeutic agents, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…